FTSE 100 today: Index slips; Marshalls slumps; U.K. retail sales miss in June
Investing.com - Baxter (NYSE: BAX) reported first quarter EPS of $0.55, $0.07 better than the analyst estimate of $0.48. Revenue for the quarter came in at $2.63B versus the consensus estimate of $2.59B.
Guidance
Baxter sees Q2 2025 EPS of $0.59-$0.63 versus the analyst consensus of $0.61.
Baxter sees FY 2025 EPS of $2.47-$2.55 versus the analyst consensus of $2.49.
Baxter’s stock price closed at $31.17. It is down -4.27% in the last 3 months and down -15.55% in the last 12 months.
Baxter saw 3 positive EPS revisions and 5 negative EPS revisions in the last 90 days. See Baxter’s stock price’s past reactions to earnings here.
According to InvestingPro, Baxter’s Financial Health score is "fair performance".
Check out Baxter’s recent earnings performance, and Baxter’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar